These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 4963794)

  • 1. Interferon in congenital rubella: response to live attenuated measles vaccine.
    Desmyter J; Rawls WE; Melnick JL; Yow MD; Barrett FF
    J Immunol; 1967 Oct; 99(4):771-7. PubMed ID: 4963794
    [No Abstract]   [Full Text] [Related]  

  • 2. An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells.
    Huygelen C; Peetermans J; Prinzie A
    Prog Med Virol; 1969; 11():107-25. PubMed ID: 4984707
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on live rubella vaccine. I. Propagation of rubella virus in developing chick embryos and its laboratory characterization.
    Okuno Y; Minekawa Y; Suzuki N; Takahashi M
    Biken J; 1968 Dec; 11(4):235-42. PubMed ID: 4976546
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory testing in rubella vaccine control.
    Hopps HE; Parkman PD; Meyer HM
    Am J Dis Child; 1969 Aug; 118(2):338-45. PubMed ID: 4978512
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospects for a rubella virus vaccine.
    Parkman PD; Meyer HM
    Prog Med Virol; 1969; 11():80-106. PubMed ID: 4984711
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biology of attenuated mumps, rubella, measles and rabies viruses. Comparative considerations on the methods of attenuation of their virulence].
    Ciaccio G
    Riv Biol; 1970; 63(1):87-129. PubMed ID: 4996066
    [No Abstract]   [Full Text] [Related]  

  • 7. Live, attenuated rubella-virus vaccine.
    Hilleman MR; Buynak EB; Weibel RE; Stokes J
    N Engl J Med; 1968 Aug; 279(6):300-3. PubMed ID: 4969117
    [No Abstract]   [Full Text] [Related]  

  • 8. Characteristics of an attenuated rubella virus strain (Cendehill).
    Huygelen C; Peetermans J
    Prog Immunobiol Stand; 1967; 3():181-7. PubMed ID: 4985508
    [No Abstract]   [Full Text] [Related]  

  • 9. Live attenuated rubella virus vaccine in a private pediatric practice.
    Nickey LN; Huchton P; Rogers PL
    Tex Med; 1973 Feb; 69(2):93-8. PubMed ID: 4734589
    [No Abstract]   [Full Text] [Related]  

  • 10. Live measles vaccine from a further attenuated strain SEVAC.
    Mares I; Drevo M; Adam E; Kubátová M; Casny J
    Prog Immunobiol Stand; 1967; 3():188-91. PubMed ID: 5379938
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on further attenuated liver measles vaccine. VII. Development and evaluation of CAM-70 measles virus vaccine.
    Okuno Y; Ueda S; Kurimura T; Suzuki N; Yamanishi K
    Biken J; 1971 Sep; 14(3):253-8. PubMed ID: 5167868
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigation and appplication of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):1-18. PubMed ID: 4985647
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on the modification of the live AIK measles vaccine. I. Adaptation of the further attenuated AIK measles virus (the strain AIK-L33) to chick embryo cells.
    Sasaki K
    Kitasato Arch Exp Med; 1974 Jun; 47(1-2):1-12. PubMed ID: 4217404
    [No Abstract]   [Full Text] [Related]  

  • 14. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
    Zäch K; Nicoara C; Germann D; Matter L
    Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mass immunization of children in Iran with live attenuated Sugiyama measles virus adapted to calf kidney cell cultures.
    Mirchamsy H; Shafyi A; Bahrami S; Nazari P; Mirzadeh M; Bassali Y
    Jpn J Exp Med; 1971 Feb; 41(1):39-48. PubMed ID: 5313449
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immune status against measles and rubella among 4 Chilean groups of different ages].
    Valenzuela MT; Vega J; Leal I; Vicente M; Young V; Vera L; Fasce R; Ramírez E
    Rev Med Chil; 1999 Mar; 127(3):359-65. PubMed ID: 10436723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
    King SM; Saunders EF; Petric M; Gold R
    Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuated rubella viruses. Laboratory and clinical characteristics.
    Meyer HM; Parkman PD; Hobbins TE; Larson HE; Davis WJ; Simsarian JP; Hopps HE
    Am J Dis Child; 1969 Aug; 118(2):155-65. PubMed ID: 4978508
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.